America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Budgeting tools can simplify your financial planning. Learn about effective resources to help you manage your budget and achieve your financial goals.
6,588 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A new survey of 150 enterprise leaders shows procurement friction is slowing AI deals as buyers struggle to map budge...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
A Gartner forecast signals a seismic shift: 40% of enterprise apps will embed AI agents by 2026. This article breaks ...
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
Investors in retirement are rethinking withdrawal timing as 2025-2026 markets swing sharply. Analysts say cash buffer...
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
Explore an investor-friendly view of Privia Health as it heads into 2025. This original analysis covers growth driver...
AI-driven data centers are reshaping the power grid, with Pennsylvania at the heart of the shift. New investments, wo...
Quantum computing is still in its early innings, and Rigetti Computing sits at a pivotal crossroads. This article bre...
In several large markets, prices are softening while buyer interest remains steady. This article explains the forces ...
Pharmaceutical tariffs could quietly raise out-of-pocket drug costs and slow medical innovation. This guide explains ...